Mechanistically, LCPAT1 could recruit retinoblastoma-binding protein 4 (RBBP4) to the promoter region of microfibril-associated protein 2 (MFAP2) to induce its expression, thus contributing to breast cancer [33]. This evidence concerns the gene MFAP2 and breast carcinoma.